Sherry Grisewood, CFA, Managing Partner, Life Sciences Research
Sherry has over 20 years experience as a research professional acting in a wide variety of equity investment and corporate-directed research activities, primarily for early stage life science and related technology companies. Through her extensive corporate and academic contact, Sherry has developed particular focus in areas of intersecting technologies such as regenerative medicine, nucleic acid based technologies, immunotherapy and therapeutic medical devices currently under development by US and ex-US life science companies.
In former analyst capacities, Sherry has served as an independent life science analyst for several regional broker dealers, served as Vice President, Senior Investment Banking analyst for Jesup Lamont Securities, was a founding analyst/Director of Life Science Research for a leading independent investment research company and acted as Director of Research for Gilford Securities. Prior to becoming an equity analyst, Sherry developed and published stock index futures and equity options trading strategies. In addition to publishing equity research, Sherry provided daily market commentary for almost 15 years, was a regular commentator on Wall Street Journal Radio and All Nippon News as well as provided market-close radio commentary for a syndicate of 21 radio stations in the Southeast US.
Sherry holds a Bachelor of Science degree with Highest Honors from Ramapo College of New Jersey and the Chartered Financial Analyst designation. Sherry is a member of the CFA Institute, NY Society of Security Analysts, and an individual member of the European Federation of Biotechnology, the Tissue Engineering and Regenerative Medicine Society International (TERMIS), the Society of Biomaterials and the American Society of Gene and Cell Therapy.